GUIRGIS, Helmy M.. Target Therapy vs the Immune Check Point Inhibitors in Lung Cancer: Costs and Caps Platform. Medical Research Archives, [S.l.], v. 11, n. 2, feb. 2023. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/3641>. Date accessed: 24 may 2024. doi: https://doi.org/10.18103/mra.v11i2.3641.